1.Construction and significance of directional expression cDNA library from human NB4 cells.
Gang, CHEN ; Wanggang, ZHANG ; Jie, FU ; Xingmei, CAO ; Wanhong, ZHAO ; Yueheng, HAN ; Aizhi, ZHAO ; Fuyang, LI ; Xinping, LIU ; Libo, YAO
Journal of Huazhong University of Science and Technology (Medical Sciences) 2004;24(1):52-4, 58
Human acute premyeloid leukemia cell cDNA expression library was constructed to screen acute premyeloid leukemia tumor antigen. Total RNA and purified mRNA were extracted from human premyeloid cell line NB4. First and second strands of cDNA were synthesized by reverse transcription. After blunting, the cDNA fragments were ligated with EcoR I adapters. Then the cDNAs were digested with Xho I, and less than 400 bp cDNA fragment was removed by Sephacryl-S400 spin column, the remaining were ligated with lambdaZAP vector. The recombinants were packaged in vitro, and a small portion of packaged phage was used to infect E. coli XL1-Blue-MRF' for titration. The recombinants were examined by color selection. In order to evaluate the size of cDNA inserts and the diversity of library, the pBK-CMV phagemid was excised from the ZAP express vector by using ExAssist helper phage with XLOLR strain, and then the pBK-CMV phagemid was digested by Xho I and EcoR I. The results showed that the NB4 cell line cDNA library consisting of 1.65 x 10(6) recombinant bacteriophages was constructed with the recombinant ratio of 99.6%. The average length of the recombinant exogenous inserts was about 1.7 kb. It was concluded that the constructed cDNA library are deserved to screen target clones.
Bacteriophages/genetics
;
DNA, Complementary/*biosynthesis
;
*DNA, Neoplasm/biosynthesis
;
DNA, Recombinant/biosynthesis
;
*Gene Library
;
Genetic Vectors
;
Leukemia, Promyelocytic, Acute/*genetics
;
Leukemia, Promyelocytic, Acute/metabolism
;
Leukemia, Promyelocytic, Acute/pathology
;
RNA-Directed DNA Polymerase/metabolism
;
Transcription, Genetic/genetics
2.MicroRNA-125b Accelerates and Promotes PML-RARa-driven Murine Acute Promyelocytic Leukemia.
Bo GUO ; Ran QIN ; Ji Jun CHEN ; Wen PAN ; Xue Chun LU
Biomedical and Environmental Sciences 2022;35(6):485-493
Objective:
Most acute promyelocytic leukemia cases are characterized by the PML-RARa fusion oncogene and low white cell counts in peripheral blood.
Methods:
Based on the frequent overexpression of miR-125-family miRNAs in acute promyelocytic leukemia, we examined the consequence of this phenomenon by using an inducible mouse model overexpressing human miR-125b.
Results:
MiR-125b expression significantly accelerates PML-RARa-induced leukemogenesis, with the resultant induced leukemia being partially dependent on continued miR-125b overexpression. Interestingly, miR-125b expression led to low peripheral white cell counts to bone marrow blast percentage ratio, confirming the clinical observation in acute promyelocytic leukemia patients.
Conclusion
This study suggests that dysregulated miR-125b expression is actively involved in disease progression and pathophysiology of acute promyelocytic leukemia, indicating that targeting miR-125b may represent a new therapeutic option for acute promyelocytic leukemia.
Animals
;
Humans
;
Leukemia, Promyelocytic, Acute/metabolism*
;
Mice
;
MicroRNAs/genetics*
;
Oncogene Proteins, Fusion/therapeutic use*
3.microRNA expression in childhood acute granulocytic leukemia and its subtypes.
Xue-qun LUO ; Ling XU ; Zhi-yong KE ; Li-bin HUANG ; Xiao-li ZHANG ; Li-dan ZHANG
Chinese Journal of Oncology 2011;33(11):831-835
OBJECTIVERecent studies have suggested that there is a close relation between microRNA and acute leukemia (AL). The aim of this study was to investigate and better understand the classification and diagnosis of AL as well as pathogenesis and prognosis of this disease.
METHODSA total of 93 children with AL and and 12 cases of idiopathic thrombocytopenic purpura (as control group) were enrolled in this study. Microarray chip analysis of their bone marrow samples was conducted to evaluate the microRNA profiles. Quantitative real-time PCR was performed for validating the abnormal expression of microRNA.
RESULTSThe microRNA expression profiles were different between acute granulocytic leukemia and acute lymphoblastic leukemia and also between the three subtypes (M1, M2 and M3) of acute granulocytic leukemia according to FAB classification based on leukemic cell differentiation. These three subtypes of leukemia could be identified by unsupervised hierarchical cluster analysis of microRNA expression and had specific up-regulation of miR-335, miR-126 and miR-125b, respectively. However, in the M2 and M3 subtypes with positive AML1-ETO and PML-RARα, respectively, which have a better prognosis, the expressions of miR-126 and miR-125b were significantly higher than those with negative AML1-ETO and PML-RARα. Further more, miR-335 and miR-146 were up-regulated in acute granulocytic leukemia observed in this study, which are different from those reported for adult patients.
CONCLUSIONSmicroRNA cascade may serve as new biomarkers for the classification and diagnosis of pediatric AL. It is also suggested that there might be different pathogenesis and prognosis between AL types related to specific expression and regulation of microRNA.
Adolescent ; Child ; Child, Preschool ; Female ; Gene Expression Profiling ; Humans ; Infant ; Leukemia, Myeloid ; classification ; genetics ; metabolism ; Leukemia, Myeloid, Acute ; genetics ; metabolism ; Leukemia, Promyelocytic, Acute ; genetics ; metabolism ; Male ; MicroRNAs ; genetics ; metabolism ; Precursor Cell Lymphoblastic Leukemia-Lymphoma ; genetics ; metabolism
4.Expression of alternatively spliced human tissue factor in acute leukemia cells.
Yi FANG ; Jia-Yi CAI ; Ji-Hua ZHONG ; Hua ZHONG ; Hai-Rong WANG ; Fang-Yuan CHEN
Journal of Experimental Hematology 2011;19(2):288-292
The high expression of tissue factor (TF) is related to the coagulation disorder in acute leukemia. TF in blood circulation is mainly expressed in cells, microparticles (MP) and alternatively spliced human tissue factor (asHTF). To elucidate the role of TF in the coagulation disorder of acute myeloid leukemia (AML), RT-PCR was performed on 6 common AML cell lines NB4, HL-60, Kasumi-1, U937, K562 and THP-1. The results showed that only NB4 and U937 cells expressed baseline full-length TF and asHTF which were proved by sequencing. The flow cytometric detection, TF activity and TF antigen tests in NB4 and U937 cells revealed that the asHTF was expressed in trace amount and almost had no activity, while the TF antigen and activity in microparticles were significantly higher than that in asHTF. It is concluded that asHTF may play an unimportant role in the coagulation disorder of AML. Microparticle associated tissue factor (MP-TF) is the predominant source of TF activity released from AML cells.
Alternative Splicing
;
HL-60 Cells
;
Humans
;
Leukemia, Promyelocytic, Acute
;
genetics
;
metabolism
;
Thromboplastin
;
genetics
;
metabolism
;
Tumor Cells, Cultured
;
U937 Cells
5.Effect of siRNA targeting PML-RARa fusion gene on activity of the acute promyelocytic leukemia cell line NB4.
Haixi LUO ; Yanpeng PAN ; Xinbao HAO ; Xianying CAO
Journal of Biomedical Engineering 2014;31(4):850-854
This study aims to investigate the effects of small interference RNA (siRNA) targeting PML-RARa mRNA on the activity of the acute promyelocytic leukemia cell line NB4. The proliferation inhibition was evaluated by MTT assay and colony-formation inhibiting test. Apoptosis was determined by flow cytometry after siRNA treatment. The results showed that the cell growth of siRNA treated group was inhibited, and the apoptosis of NB4 could be induced. The siRNA targeting PML-RARα mRNA might be a valid therapy of acute promyelocytic leukemia.
Apoptosis
;
Cell Cycle
;
Cell Line, Tumor
;
Humans
;
Leukemia, Promyelocytic, Acute
;
genetics
;
metabolism
;
Oncogene Proteins, Fusion
;
genetics
;
metabolism
;
RNA, Messenger
;
genetics
;
RNA, Small Interfering
;
genetics
6.Involvement of PML proteins in treatment of acute promyelocytic leukemia with arsenic trioxide.
Rui HAO ; Lide SU ; Yiming SHAO ; Na BU ; Liya MA ; Hua NARANMANDURA
Journal of Zhejiang University. Medical sciences 2018;47(5):541-551
Promyelocytic leukemia (PML) protein, a tumor suppressor, plays an important role in patients with acute promyelocytic leukemia (APL) receiving arsenic trioxide (AsO) therapy. APL is a M3 subtype of acute myeloid leukemia (AML), which is characterized by expression of PML-RARα (P/R) fusion protein, leading to the oncogenesis. AsO is currently used as the first-line drug for patients with APL, and the mechanism may be:AsO directly binds to PML part of P/R protein and induces multimerization of related proteins, which further recruits different functional proteins to reform PML nuclear bodies (PML-NBs), and finally it degraded by SUMOylation and ubiquitination proteasomal pathway. Gene mutations may lead to relapse and drug resistance after AsO treatment. In this review, we discuss the structure and function of PML proteins; the pathogenesis of APL induced by P/R fusion protein; the involvement of PML protein in treatment of APL patient with AsO; and explain how PML protein mutations could cause resistance to AsO therapy.
Antineoplastic Agents
;
therapeutic use
;
Arsenic Trioxide
;
therapeutic use
;
Drug Resistance, Neoplasm
;
genetics
;
Humans
;
Leukemia, Promyelocytic, Acute
;
drug therapy
;
Mutation
;
Oncogene Proteins, Fusion
;
metabolism
;
Promyelocytic Leukemia Protein
;
chemistry
;
genetics
;
metabolism
7.microRNAs expression profile in acute promyelocytic leukemia cell differentiation induced by all-trans retinoic acid and arsenic trioxide.
Yong WU ; Xian-fang LI ; Jing-hui YANG ; Xiao-ying LIAO ; Yuan-zhong CHEN
Chinese Journal of Hematology 2012;33(7):546-551
OBJECTIVETo study the expression profile of microRNAs in acute promyelocytic leukemia (APL) cells during differentiation.
METHODSDifferentiation of APL cell line NB4 cells was induced by all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3). Morphological and immunological assay was performed by Wright-Giemsa staining and flow-cytometric analysis of CD11b surface expression. During in vitro NB4 differentiation induced by ATRA and As2O3, microRNA expression profiles (miR-15b, miR-16, miR-34a, miR-107, miR-124a, miR-146, miR-155, miR-181a, miR-223, miR-342, let7c) were detected by real time RT-PCR, and the relative expression level of microRNAs were quantitatively analyzed by using 2(-ΔΔCt), and compared with that of control group. Meanwhile, the microRNA expression profiles were also detected in 15 newly diagnosed APL patients and 15 complete remission (CR) APL cases by real time RT-PCR, and the relative expression level of microRNA was quantitated by using 2(-ΔCt), and compared with that of control group (newly diagnosed APL as control group). These data were expressed as x(-) ± s, and differences between groups were examined using t test. P < 0.05 was considered statistically significant.
RESULTSThe expression levels of miR-15b, miR-16, miR-107, miR-223 and miR-342 in NB4 differentiation group were obviously up-regulated (3.40, 4.22, 5.41, 20.03 and 5.29 folds higher in ATRA treated NB4 cells than that of control group respectively, and 3.62, 2.49, 2.58, 4.27 and 1.94 folds higher in AS2O3 treated NB4 cells than that of control group respectively), except for miR-15b, the expression levels of miR-16, miR-107, miR-223 and miR-342 in ATRA treated group was significantly higher than that in As2O3 treated group. The relative expression levels of miR-15b, miR-16, miR-107, miR-181a, miR-223 and miR-342 were 0.4137, 0.6367, 0.1260, 0.0522, 0.6611, 0.0280 in APL CR group, and 0.0751, 0.2022, 0.0425, 0.3064, 0.1733, 0.0090 in newly diagnosed APL group, respectively. The expression level of miR-15b, miR-16, miR-107, miR-223 and miR-342 in APL CR group were significantly upregulated compared with that of newly diagnosed APL groups (P < 0.05), while the expression level of miR-181a was significantly downregulated (P < 0.05).
CONCLUSIONSpecific expression of microRNA profiles is a key contributing factor in the differentiation of APL.
Arsenicals ; pharmacology ; Cell Differentiation ; drug effects ; Humans ; Leukemia, Promyelocytic, Acute ; genetics ; metabolism ; MicroRNAs ; genetics ; metabolism ; Oxides ; pharmacology ; RNA, Messenger ; genetics ; Tretinoin ; pharmacology ; Tumor Cells, Cultured
8.Acute promyelocytic leukemia with CD59 deficiency.
Hui WEI ; Zheng TIAN ; Xiao-Jing WANG ; Kai-Qi LIU ; Cui-Ping ZHANG ; Hui-Jun WANG ; Ying-Chang MI ; Jian-Xiang WANG
Journal of Experimental Hematology 2010;18(5):1105-1108
CD59 is a glycosyl-phosphatidyl inositol-anchored protein with the capacity to block the formation of membrane-attack complex, and protect the cells from complement-mediated cytolysis. The study was aimed to investigate whether CD59 is deficient in acute promyelocytic leukemia (APL) blast cells. Expression of CD59 on APL blast cells was analysed by flow cytometry. Expression of CD59 on NB4 cells was determined by flow cytometry before and after treating with all trans retinoic acid (ATRA). Pig-A gene coding region was sequenced. The results showed that the deficiency of CD59 expression in 12 out of 19 APL samples was found, its incidence was significantly higher than that in other acute myeloid leukemia (AML) samples (deficiency of CD59 expression in 14 of 40 non-APL AML samples, p=0.042). The expression of CD59 became normal after the patients achieved complete remission (CR), which indicated that the deficient of CD59 expression was only found in APL blast cells, but also found in APL cell line NB4 cells. The expression of CD59 was not changed after NB4 cells were induced to differentiate by ATRA. Sequencing pig-A gene coding region of NB4 cells and one APL patient with deficiency of CD59 displayed that the mutation of pig-A gene was not observed, therefore the deficiency of CD59 expression in APL cells did not result from mutation of pig-A gene. It is concluded that the deficiency of CD59 expression exists in APL blast cells more probably.
Adolescent
;
Adult
;
CD59 Antigens
;
genetics
;
metabolism
;
Female
;
Humans
;
Leukemia, Promyelocytic, Acute
;
genetics
;
metabolism
;
Male
;
Membrane Proteins
;
metabolism
;
Middle Aged
;
Tretinoin
;
pharmacology
;
Tumor Cells, Cultured
;
Young Adult
9.Expression level changes of inhibitor of differentiation 1 during ATRA-induced acute promyelocytic leukemia cells differentiation.
Pei-zheng ZHENG ; Chun-jun ZHAO ; Hui-yong FAN ; Yu-long CHEN
Chinese Journal of Hematology 2008;29(6):366-369
OBJECTIVETo study the role of inhibitor of differentiation 1 (ID1) in ATRA-induced acute promyelocytic leukemia (APL) cells differentiation.
METHODSThe expression of ID1 was detected by cDNA microarray, cycloheximide inhibition test, real-time RT-PCR and western blot.
RESULTSThe expression of ID1 gene was up-regulated in ATRA-induced NB4 cells and APL cells from two patients and was independent on other proteins synthesis. ID1 expression level reached the peak at 2 h in NB4 cells induced by ATRA, its relative expression level was (359.4 +/- 48.7)-fold greater than control. ID1 expression level reached the peak at 2 h in bone marrow cells from APL patents treated with ATRA, and its level detected 3 times in one of the patient was (311.1 +/- 48.7) fold of control. The expression of ID1 protein was not up-regulated in ATRA resistant NB4-R2 cells after ATRA treatment.
CONCLUSIONID1 may be involved in ATRA-induced granulocytic differentiation as an ATRA-targeted gene.
Antineoplastic Agents ; therapeutic use ; Cell Differentiation ; Humans ; Inhibitor of Differentiation Protein 1 ; genetics ; metabolism ; Leukemia, Promyelocytic, Acute ; drug therapy ; metabolism ; pathology ; Oligonucleotide Array Sequence Analysis ; Tretinoin ; therapeutic use
10.Expression changes of genes related to calcium pathway in all-trans retinoic acid-induced differentiation of APL cells.
Pei-Zheng ZHENG ; Juan HOU ; Ying-Ping CAO ; Dong-Hui ZHU ; Chun-Jun ZHAO ; Hui-Yong FAN
Journal of Experimental Hematology 2010;18(2):282-285
In order to investigate the role of calcium pathway in myeloid differentiation, the expression level of genes related to calcium pathway in all-trans retinoic acid (ATRA)-induced NB4 cell differentiation was detected by cDNA microarray, some of which were further confirmed by quantitative real time RT-PCR. At the same time, the expressions of these genes in NB4-R1 cells treated with ATRA and 8-CPT-cAM P alone or in combination, and in differentiation of primary cells from ATRA-induced newly diagnosed APL patients were detected by real time RT-PCR. The results showed that during differentiation of ATRA-induced NB4 cells, the expressions of genes related to calcium concentration had changed, the expression of downstream effectors in calcium pathway was up-regulated and confirmed by real time RT-PCR assay. The expression of genes related to calcium concentration did not change significantly when NB4-R1 cells were treated by ATRA or 8-CPT-cAMP alone, but expression changes of those genes were similar to the changes in ATRA-induced NB4 cell differentiation when NB4-R1 cells were treated by ATRA combined with 8-CPT-cAMP. In addition, the expression changes of those genes in ATRA-induced primary cells of patients with APL were also similar to changes in ATRA-induced NB4 cell differentiation. It is concluded that calcium pathway may be involved in ATRA-induced differentiation in APL cell.
Calcium
;
metabolism
;
Cell Differentiation
;
drug effects
;
Gene Expression Regulation, Leukemic
;
Humans
;
Leukemia, Promyelocytic, Acute
;
genetics
;
metabolism
;
Signal Transduction
;
Tretinoin
;
pharmacology
;
Tumor Cells, Cultured